4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-13-004541
CIK 0000875622operating
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 8:48 PM ET
Size
6.6 KB
Accession
0001062993-13-004541
Insider Transaction Report
Form 4
Morgan Henry
Director
Transactions
- Sale
Common Stock, $0.001 par value
2013-09-03$18.38/sh−1,204$22,133→ 35,043 total - Sale
Common Stock, $0.001 par value
2013-08-30$18.30/sh−946$17,312→ 36,247 total
Footnotes (2)
- [F1]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.30 to $18.30. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $18.35 to $18.45. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 8:48 PM ET
- Size
- 6.6 KB